Related Experiment Videos
Profound reversible CD4+ T lymphocytopenia in a severely uremic patient
F I Polsky1, B Dannemann, W H Hemmert
1Department of Internal Medicine, Utah Valley Regional Medical Center, Provo 84604.
Insights
A human immunodeficiency virus-negative patient with severe kidney failure experienced significantly low T lymphocyte counts. Chronic hemodialysis effectively normalized these counts within 12 weeks, reversing the cytopenias.
Area of Science:
- Immunology
- Nephrology
- Hematology
Background:
- Uremia, a condition of severe kidney failure, can lead to immune system dysregulation.
- Lymphopenia, characterized by low lymphocyte counts, is observed in some uremic patients.
- Specific T lymphocyte subsets (CD4+, CD8+, CD3+) play critical roles in immune function.
Observation:
- A human immunodeficiency virus antibody-negative patient with profound uremia presented with markedly reduced CD4+, CD8+, and CD3+ T lymphocyte counts.
- These lymphocyte counts were significantly lower than those reported in other lymphopenic uremic individuals.
- The patient exhibited severe cytopenias affecting T lymphocyte populations.
Findings:
- High-efficiency chronic hemodialysis was initiated as a treatment for the patient's uremia.
- Following 12 weeks of hemodialysis, a significant correction of the T lymphocyte counts was observed.
- The CD4+, CD8+, and CD3+ T lymphocyte counts returned to normal ranges.
Implications:
- Chronic hemodialysis may effectively reverse severe T lymphopenias associated with uremia.
- This case highlights the potential impact of renal failure on immune cell populations.
- Further research is warranted to understand the mechanisms linking uremia, lymphopenia, and the efficacy of dialysis in immune restoration.
Abstract:
We report a human immunodeficiency virus antibody-negative, profoundly uremic patient who presented with a CD4+ T lymphocyte count of 133/mm3, a CD8+ T lymphocyte count of 77/mm3, and a CD3+ T lymphocyte count of 259/mm3. These values decrease significantly below reported levels in other lymphopenic uremic patients. High-efficiency chronic hemodialysis resulted in correction of these cytopenias to a normal range within 12 weeks.